RE:RE:RE:Clinically cancer free ! ! ! :)The MD&A would indicate that they are at farther along with at least one of the 3. The previous NR said 7,8,9 remained to be enrolled but the MD&A says:
"Enrollment for the remaining three patients to be treated at the Therapeutic Dose is currently
ongoing with Theralase’s clinical partner at University Healthcare Network (“UHN”), Toronto, Ontario, Canada."
Maybe I'm reading too much into it but I believe one if not two will be treated next week after the 90 day scope of patient 6. That way they will have some 7 day data to look over when the MSAB meets later this month "to finalize the design of a Health Canada and FDA Phase II NMIBC clinical study, with a primary endpoint of efficacy"
LaserStock29 wrote: We're just along for the ride as retail folk. I'll take $3 on any Monday morning from now till before ph2b.. Patient 6 should be 90day already And with any luck those identified patients 789 are being enrolled and treated. May is bladder cancer month Precommercial Pre Phase 2 value is $2-3 as I've shown a zillion times. So I'd welcome this.